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Copyright © 2010 JCBN Summary The clinical features of patients reflux esophagitis without any symptoms have not
been clearly demonstrated. This study evaluated the clinical features of patients with endoscopy-
positive reflux esophagitis, who did not complain of symptoms, as detected by brief questioning
by nursing staffs. Eight thousand and thirty-one patients not taking medication for gastro-
intestinal disease, were briefly asked about the presence of heartburn, dysphagia, odynophagia
and acid regurgitation by nursing staffs before endoscopy for assessment of esophagitis utiliz-
ing the Los Angeles Classification. Endoscopically, 1199 (14.9%) patients were classified as
positive for reflux esophagitis. The endoscope positive subjects who complain heartburn were
539/1199 (45.0%).The endoscope positive subjects who do not complain symptoms were 465 in
1199 positive reflux esophagitis (38.8%). We compared endoscopic positive subjects without
any complain by brief question by nursing staffs to endoscopic positive subjects with heartburn.
Male gender, no obesity, absence of hiatus hernia, and low-grade esophagitis were associated
with endoscopy-positive patients who do not complain of symptoms. The results of this study
indicated correct detection of clinical symptoms of reflux esophagitis might be not easy with
brief questioning by nursing staffs before endoscopic examination.
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Introduction
Gastroesophageal acid reflux causes a variety of clinical
symptoms, such as heartburn, acid regurgitation, dysphagia
and retrosternal pain. These reflux symptoms show varying
severity, frequency and incidence [1]. Endoscopic evalua-
tion is a reliable method for evaluation of esophagitis [1,
2] and the Los Angeles Classification is one of the most
accepted grading systems for esophageal mucosal breeches
[2, 3]. It is widely accepted that such typical clinical symp-
toms of gastroesophageal reflux reflect the presence and
grading of endoscopic reflux esophagitis. Clinical symptoms
might vary between countries and races [4, 5], and several
studies from Japan have indicated a relationship between
symptoms and reflux esophagitis [6–17]. Our coworkers
have previously indicated that clinical symptoms detected
by short questions before endoscopic examination were not
always equivalent to grading of reflux esophagitis, espe-
cially regarding dysphagia, in a cross-sectional study of
8031 subjects [8, 18]. The present study aimed to assess
limitation of brief asking of symptoms before endoscopicT. Takashima et al.
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examination by nursing staffs, and to assess clinical charac-
teristics of patients reflux esophagitis without any symptoms
by this process.
Materials and Methods
Patients
This study re-analyzed, focused on symptoms detection
by nursing stuff, data detected in the previous study [8],
and the recruited method described briefly as follows:
Patients were recruited from 23 hospitals, including the Saga
Medical School, in Saga Prefecture (population, ~800,000),
and were not randomly selected community samples as in
our previous studies [8]. A total of 8031 Japanese patients
(4120 male, 3911 female; aged >30 years, mean 59.4) were
enrolled in the present multicenter study from September
1996 to October 1998. Among the 8031 patients, 6166 were
outpatients who visited the 23 hospitals but did not receive
medication for gastrointestinal disease, and the other 1865
were mainly selected from those receiving secondary
examinations from a primary gastroenterological mass survey
conducted in Saga Prefecture (50000/year), or patients who
visited the hospitals for a routine physical examination. The
study was conducted according to the provisions of the
Declaration of Helsinki. The clinical study committee of
Saga Medical School Hospital approved the study, and all
patients were informed about the basic concept of the
present study and of gastrointestinal endoscopy. Patients
were excluded if they had received medication for gastro-
intestinal disease, or had had laparotomy. Patients who
had had a major psychotic episode, mental retardation or
dementia were also excluded.
Symptoms assessment
Before endoscopic examination, each patient was inter-
viewed by nursing staffs who briefly asked questions
regarding current clinical symptoms, including heartburn,
dysphagia, odynophagia (chest pain or irritation on swal-
lowing) and acid regurgitation. The patients simply answered
“yes” or “no”. Endoscopists were blinded to the interview
results before their evaluation of reflux esophagitis.
Upper gastrointestinal endoscopy
Upper gastrointestinal endoscopy for evaluation of reflux
esophagitis was performed by experienced endoscopists,
certified by the Japan Gastroenterological Endoscopy
Society. The endoscopists were directed to grade esophageal
mucosal breaks with esophagitis according to the Los
Angeles Classification of Esophagitis in 1996 [2]. To reduce
interobserver variation in the grading of esophagitis, pre-
testing and several meetings were held before this study
was conducted. The criteria for the diagnosis of esophagitis
were: grade A, one or more mucosal breaks, each no longer
than 5 mm; grade B, at least one mucosal break more than
5 mm long; grade C, at least one mucosal break, continuous
between the tops of two or more mucosal folds; grade D,
circumferential mucosal break. The endoscopists were also
required to check for upper gastrointestinal diseases such as
gastric and/or duodenal ulcers, polyps and cancer, but dis-
orders other than esophagitis were not evaluated in this study.
Statistical analysis
We analyzed data from endoscopy-positive patients who
did not complain of symptoms. Most of the analyses gave
rise to contingency tables by the χ2 test of independence and
the Cochran–Mantel–Haenzel method. We used a logistic
regression model to compute the odds ratio (OR) and the
95% confidence interval (CI) in multivariate modeling.
Age, sex and other symptoms were adjusted to calculate the
OR. Two-tailed p values <0.05 were considered significant.
Statistical analyses were performed with the SAS statistical
package (version 6.08; SAS Inc., Cary, NC).
Results
Esophagitis was found in 1199/8031 (14.9%) patients.
The grade of reflux esophagitis was evaluated by endoscopy,
as follows: grade A, 717 (8.9%) patients; grade B, 341
(4.2%); and grade C + D, 141 (1.8%). Heartburn was the
most common symptom of reflux esophagitis and was found
in 539 of 1199 (45.0%) endoscopy-positive patients. Four
hundred and sixty-five of 1199 (38.8%) of endoscopy-
positive patients did not complain of any symptoms. The
clinical characteristics of Group I (esophagitis with heart-
burn) and Group II (esophagitis without any symptoms)
were compared. As indicated in Table 1, the number of
males was significantly higher in Group II compared to
Group I. Body mass index (BMI) was significantly higher in
Group I than in Group II. The rate of hiatus hernia was high
in Group I, and endoscopic esophagitis was significantly
more severe in Group I compared to Group II. Other factors
including age, smoking and alcohol consumption did not
differ between the two groups.
Univariate analysis of clinical characteristics of patients
in Groups I and II is shown in Table 2. This indicated
that gender, BMI, hiatus hernia, and severity of reflux
were closely related to the presence or absence of clinical
symptoms of endoscopic reflux esophagitis. Results of
multivariate analysis are shown in Table 3. As indicated,
male gender, absence of hiatus hernia, patients not over-
weight, and absence of severe reflux esophagitis (grades C
and D) were clinical characteristics of Group II patients
compared to Group I.Symptoms of Reflux Esophagitis and Nursing Staffs
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Discussion
In the present study, we evaluated endoscopy-positive
patients who did not complain of symptoms by brief
questions by nursing staffs, as in our previous studies [8, 18],
and who had not been given medication for gastrointestinal
disease. Precise and structured questionnaires for reflux
symptoms are useful for diagnosis of gastroesophageal
reflux disease, and heartburn is a major and specific
symptom that is associated with abnormal manometric and
pH results [19–25]. It has also been shown that a brief
and simple questionnaire is reliable for noting changes in
reflux symptoms [10, 26]. We did not use precise question-
naires in this study, because the aim was to establish whether
patients who suffered from reflux symptoms in daily life
could be detected by brief questioning by nursing staffs.
This consisted of briefly asking the patients about heartburn,
dysphagia, odynophagia and acid regurgitation before
endoscopic examination, and the patients simply answered
“yes” or “no”.
The present study focused on patients with endoscopy-
positive reflux esophagitis without clinical symptoms,
assessed by brief questioning by nursing staffs. The number
of endoscopy-positive patients who did not complain of any
symptoms was ~6% (465/8031) of the whole group tested.
The ratio of patients without symptoms among those with
endoscopic esophagitis was relatively high, 465/1199
(38.8%). This high ratio was partly due to the specific
conditions of the present study. The patients surveyed were
limited to outpatients who did not receive medication for
gastrointestinal disease. The patients were selected from
those receiving secondary examinations from a primary
gastroenterological mass survey conducted in Saga Prefec-
ture, and the patients visited the hospital for a routine
physical examination. The level of severe esophagitis in
this study was low, around 2%. The nursing staffs asked
patients brief questions, and patients simply answered “yes”
or “no”.
The cross-sectional study with a large subject population
indicated that the characteristics of patients with endoscopic
esophagitis without any clinical symptoms were male gender,
absence of obesity and hiatus hernia, and low-grade
esophagitis, compared to patients with endoscopic eso-
phagitis with heartburn. We performed a large number of
routine endoscopic examinations, because upper gastro-
intestinal endoscopy is an examination routinely performed
once a year in Japan due to the high prevalence of gastric
cancer and squamous cell cancer of the esophagus. As a
Table 1. Analysis evaluated by χ2 test of the relationship between several factors in endoscopy-positive subjects
Group I: endoscopic esophagitis with heartburn. Group II: endoscopic esophagitis without any symptoms. Grade: evaluation of
reflux esophagitis with Los Angles Classification [2]. BMI: body mass index (kg/m2)
Factors Group I (n = 539) Group II (n = 465) p value
Sex (males/females) 270/269 276/189 0.003
Age (30/40/50/60/70/80 years) 46/103/97/129/117/47 38/79/83/113/109/43 0.955
BMI (<25:25≤) 369:142 356:82 0.001
Hiatus hernia (+/−) 279/260 186/279 <0.001
Smoking (+/−) 176/363 170/295 0.194
Alcohol drinking (+/−) 231/308 202/263 0.852
Grade (A:B:C:D) 271:187:58:23 332:100:26:7 <0.001
Table 2. Univariate analysis evaluated between Groups I and II
**p<0.01. OR was adjusted for each symptom, age and sex.
Group I: endoscopic esophagitis with heartburn. Group II:
endoscopic esophagitis without any symptoms. BMI: body mass
index (kg/m2).
Factors OR 95% CI
Sex (males/females) 1.46** 0.54–0.88
BMI <25 1 reference
BMI 25≤ 0.60** 0.44–0.82
Hiatus hernia (+/−) 0.62** 0.48–0.80
Esophagitis: grades A + B 1 reference
Esophagitis: grades C + D 0.43** 0.28–0.66
Table 3. Multivariate analysis evaluated between Groups I and II
*p<0.05, **p<0.01. OR was adjusted for each symptom, age and
sex. Group I: endoscopic esophagitis with heartburn. Group II:
endoscopic esophagitis without any symptoms. BMI: body mass
index (kg/m2).
Factors OR 95% CI
Sex (males/females) 1.35* 0.57–0.98
BMI <25 1 reference
BMI 25≤ 0.62** 0.45–0.84
Hiatus hernia (+/−) 0.69** 0.53–0.90
Esophagitis: grades A + B 1 reference
Esophagitis: grades C + D 0.45** 0.29–0.72T. Takashima et al.
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result, the characteristics of the esophagitis patients without
any symptoms questioned by nursing staffs were estimated
in this study.
Endoscopic examination and clinical symptoms are most
reliable for diagnosis of reflux esophagitis in normal clinical
situations [1,  4,  5,  8,  27–29]. This study indicated that
detection of clinical symptoms of reflux esophagitis was not
easy using a short questionnaire administered by nursing
staffs. This suggests that precise interview for clinical
symptoms and/or a questionnaire for reflux esophagitis
might be required for nursing staffs and health practitioners
to carry out precise diagnosis of reflux esophagitis.
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